IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells (2023)
Fonte: Immunologic Research. Unidade: FMVZ
Assuntos: NEOPLASIAS MAMÁRIAS, IMUNOTERAPIA, ENZIMAS
ABNT
AZIMNASAB‐SORKHABI, Parviz et al. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunologic Research, v. 71, p. 679-686, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12026-023-09378-0. Acesso em: 06 nov. 2025.APA
Azimnasab‐sorkhabi, P., Soltani‐asl, M., Yoshinaga, T. T., Gomes, C. de O. M. -S., & Kfoury Junior, J. R. (2023). IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunologic Research, 71, 679-686. doi:10.1007/s12026-023-09378-0NLM
Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Gomes C de OM-S, Kfoury Junior JR. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells [Internet]. Immunologic Research. 2023 ; 71 679-686.[citado 2025 nov. 06 ] Available from: https://doi.org/10.1007/s12026-023-09378-0Vancouver
Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Gomes C de OM-S, Kfoury Junior JR. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells [Internet]. Immunologic Research. 2023 ; 71 679-686.[citado 2025 nov. 06 ] Available from: https://doi.org/10.1007/s12026-023-09378-0
